Healius Ltd (HLS) - Total Assets
Based on the latest financial reports, Healius Ltd (HLS) holds total assets worth AU$1.77 Billion AUD (≈ $1.25 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Healius Ltd shareholders equity for net asset value and shareholders' equity analysis.
Healius Ltd - Total Assets Trend (1998–2025)
This chart illustrates how Healius Ltd's total assets have evolved over time, based on quarterly financial data.
Healius Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Healius Ltd's total assets of AU$1.77 Billion consist of 14.2% current assets and 85.8% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 3.2% |
| Accounts Receivable | AU$144.90 Million | 8.2% |
| Inventory | AU$29.80 Million | 1.7% |
| Property, Plant & Equipment | AU$938.50 Million | 52.8% |
| Intangible Assets | AU$56.60 Million | 3.2% |
| Goodwill | AU$430.00 Million | 24.2% |
Asset Composition Trend (1998–2025)
This chart illustrates how Healius Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Healius Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Healius Ltd's current assets represent 14.2% of total assets in 2025, an increase from 11.6% in 1998.
- Cash Position: Cash and equivalents constituted 3.2% of total assets in 2025, down from 7.2% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, a decrease from 130.0% in 1998.
- Asset Diversification: The largest asset category is property, plant & equipment at 52.8% of total assets.
Healius Ltd Competitors by Total Assets
Key competitors of Healius Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB
|
India | Rs31.46 Billion |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
RHYTHM Biosciences Ltd
AU:RHY
|
Australia | AU$3.10 Million |
|
Check-Cap Ltd.
NASDAQ:MBAI
|
USA | $7.49 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
Healius Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.58 | 1.29 | 0.47 |
| Quick Ratio | 0.50 | 1.25 | 0.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$-186.70 Million | AU$233.80 Million | AU$-328.20 Million |
Healius Ltd - Advanced Valuation Insights
This section examines the relationship between Healius Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.69 |
| Latest Market Cap to Assets Ratio | 0.10 |
| Asset Growth Rate (YoY) | -40.4% |
| Total Assets | AU$1.78 Billion |
| Market Capitalization | $179.83 Million USD |
Valuation Analysis
Below Book Valuation: The market values Healius Ltd's assets below their book value (0.10x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Healius Ltd's assets decreased by 40.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Healius Ltd (1998–2025)
The table below shows the annual total assets of Healius Ltd from 1998 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$1.78 Billion ≈ $1.26 Billion |
-40.43% |
| 2024-06-30 | AU$2.98 Billion ≈ $2.11 Billion |
-18.35% |
| 2023-06-30 | AU$3.65 Billion ≈ $2.58 Billion |
-11.69% |
| 2022-06-30 | AU$4.14 Billion ≈ $2.93 Billion |
+9.38% |
| 2021-06-30 | AU$3.78 Billion ≈ $2.68 Billion |
-17.57% |
| 2020-06-30 | AU$4.59 Billion ≈ $3.25 Billion |
+36.85% |
| 2019-06-30 | AU$3.35 Billion ≈ $2.37 Billion |
+7.24% |
| 2018-06-30 | AU$3.13 Billion ≈ $2.21 Billion |
+0.39% |
| 2017-06-30 | AU$3.11 Billion ≈ $2.20 Billion |
-14.08% |
| 2016-06-30 | AU$3.62 Billion ≈ $2.56 Billion |
-7.49% |
| 2015-06-30 | AU$3.92 Billion ≈ $2.77 Billion |
+4.70% |
| 2014-06-30 | AU$3.74 Billion ≈ $2.65 Billion |
-6.09% |
| 2013-06-30 | AU$3.98 Billion ≈ $2.82 Billion |
+3.18% |
| 2012-06-30 | AU$3.86 Billion ≈ $2.73 Billion |
+0.95% |
| 2011-06-30 | AU$3.83 Billion ≈ $2.71 Billion |
+3.50% |
| 2010-06-30 | AU$3.70 Billion ≈ $2.62 Billion |
-2.18% |
| 2009-06-30 | AU$3.78 Billion ≈ $2.67 Billion |
-21.25% |
| 2008-06-30 | AU$4.80 Billion ≈ $3.40 Billion |
+691.14% |
| 2007-06-30 | AU$606.50 Million ≈ $429.14 Million |
+11.40% |
| 2006-06-30 | AU$544.42 Million ≈ $385.21 Million |
+21.55% |
| 2005-06-30 | AU$447.90 Million ≈ $316.92 Million |
+48.12% |
| 2004-06-30 | AU$302.39 Million ≈ $213.96 Million |
+3.44% |
| 2003-06-30 | AU$292.33 Million ≈ $206.84 Million |
+3.17% |
| 2002-06-30 | AU$283.35 Million ≈ $200.49 Million |
+28.35% |
| 2001-06-30 | AU$220.78 Million ≈ $156.21 Million |
+36.07% |
| 2000-06-30 | AU$162.25 Million ≈ $114.80 Million |
+88.86% |
| 1999-06-30 | AU$85.91 Million ≈ $60.79 Million |
+113.35% |
| 1998-06-30 | AU$40.27 Million ≈ $28.49 Million |
-- |
About Healius Ltd
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more